切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2019, Vol. 16 ›› Issue (03) : 211 -216. doi: 10.3877/cma.j.issn.1672-6448.2019.03.011

所属专题: 文献

浅表器官超声影像学

剪切波弹性成像联合BRAF V600E预测甲状腺乳头状癌中央区淋巴结转移的价值
王珏1, 闻卿2, 贲志飞3, 董汝锋4, 戴磊5, 黄品同2,()   
  1. 1. 310009 杭州,浙江大学医学院附属第二医院超声科(目前工作于中国科学院大学宁波华美医院超声科)
    2. 310009 杭州,浙江大学医学院附属第二医院超声科
    3. 315010 中国科学院大学宁波华美医院超声科
    4. 315010 宁波市中医院超声科
    5. 315010 中国科学院大学宁波华美医院甲状腺外科
  • 收稿日期:2018-11-28 出版日期:2019-03-01
  • 通信作者: 黄品同
  • 基金资助:
    国家自然科学基金(81527803,81420108018); 宁波市自然基金(2017A610196)

Value of share wave elastography combined with BRAFV600E in predicting central lymph nodes metastasis of papillary thyroid carcinoma

Jue Wang1, Qing Wen2, Zhifei Ben3, Rufeng Dong4, Lei Dai5, Pintong Huang2,()   

  1. 1. Department of Ultrasound, the Second Aiffiliated Hospital of Zhejiang University School of Medicine, HangZhou 310009, China (now work in the HwaMei Hosptial, University of Chinese Academy of Sciences)
    2. Department of Ultrasound, the Second Aiffiliated Hospital of Zhejiang University School of Medicine, HangZhou 310009, China
    3. Department of Ultrasound, HwaMei Hosptial, University of Chinese Academy of Sciences, Ningbo 315010, China
    4. Department of Ultrasound, Ningbo Municipal Hospital of Traditional Chinese Medicine, Ningbo 315010, China
    5. Department of Ultrasound Thyroid Surgery, HwaMei Hosptial, University of Chinese Academy of Sciences, Ningbo 315010, China
  • Received:2018-11-28 Published:2019-03-01
  • Corresponding author: Pintong Huang
  • About author:
    Corresponding author: Huang Pintong, Email:
引用本文:

王珏, 闻卿, 贲志飞, 董汝锋, 戴磊, 黄品同. 剪切波弹性成像联合BRAF V600E预测甲状腺乳头状癌中央区淋巴结转移的价值[J/OL]. 中华医学超声杂志(电子版), 2019, 16(03): 211-216.

Jue Wang, Qing Wen, Zhifei Ben, Rufeng Dong, Lei Dai, Pintong Huang. Value of share wave elastography combined with BRAFV600E in predicting central lymph nodes metastasis of papillary thyroid carcinoma[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2019, 16(03): 211-216.

目的

探讨剪切波弹性成像(SWE)联合BRAFV600E预测甲状腺乳头状癌(PTC)中央区淋巴结转移的价值。

方法

选取2017年1月至2018年5月浙江大学附属第二医院经手术病理证实为PTC患者217例,共217个结节,所有患者术前均行常规超声检查、SWE、BRAFV600E检测,术中均行预防性颈部中央区淋巴结清扫。以术后病理结果为"金标准",采用独立样本t检验比较发生中央区淋巴结转移及未发生中央区淋巴结转移两组间的SWE检查的弹性模量值最大值(Emax)、平均值(Emean)及最小值(Emix)值之间的差异;采用χ2检验比较BRAFV600E突变者与未突变者发生中央区淋巴结转移的差异;绘制受试者工作特征ROC曲线比较SWE各参数及其联合BRAFV600E预测PTC中央区淋巴结转移的效能。

结果

两组间的Emax、Emean、Emin比较,差异均有统计学意义(t=4.49、8.11、3.23,P均<0.01),且Emean预测效能优于Emax、Emin。BRAFV600E突变者与未突变者发生中央区淋巴结转移比较,差异有统计学意义(χ2=16.16,P<0.01)。SWE联合BRAFV600E预测PTC中央区淋巴结转移特异度、准确性、阴性预测值、阳性预测值均高于单独应用SWE及BRAFV600E,且差异均有统计学意义(χ2=64.769、35.406、22.647、20.247,P均<0.01)。

结论

SWE与BRAFV600E联合应用可以显著提高预测PTC中央区淋巴结转移的特异度、准确性、阴性预测值、阳性预测值。

Objective

To investigate the value of share wave elastography (SWE) combined with BRAFV600E in predicting central lymph nodes metastasis of papillary thyroid carcinoma (PTC).

Methods

This study collected 217 PTC from 217 patients diagnosed as PTC by surgical pathology,all patients are confirmed by conventional ultrasonography, SWE examination, BRAF V600E gene detection and central neck dissection for preventive. Taking postoperative pathological results as gold standard, the independent t test was used to compared the differences in SWE between groups with and without central lymph nodes metastasis; the chi-square test was used to compare the difference of BRAFV600E between the two groups; and to use the receiver operating characteristic (ROC) curve to investigate the diagnostic efficacy of SWE, BRAFV600E and their combination in predicting central lymph nodes metastasis of PTC.

Results

The differences of PTC Emax, Emean, Emin between the two groups showed statistically significant (t=4.49, 8.11, 3.23, all P<0.01), and the predictive value of Emean was higher than Emax、Emin. The difference of BRAFV600E between the two groups showed statistically significant (χ2=16.16, P<0.01). The specificity, accuracy, negative predictive value and positive predictive value of SWE combined with BRAFV600E were all higher than single SWE and BRAFV600E with statistical significant (χ2=64.769, 35.406, 22.647, 20.247, all P<0.01).

Conclusions

SWE combined with BRAFV600E can significantly improve the specificity, accuracy, negative predictive value and positive predictive value in predicting central lymph nodes metastasis of PTC.

图1 病理证实PTC伴中央区淋巴结转移患者的超声图像。图a二维声像图;图b SWE质量模式显示可信度为100%;图c SWE速度模式显示Emean:45.75 kPa
图2 病理证实PTC未发生中央区淋巴结转移患者的超声图像。图a二维声像图;图b SWE质量模式显示可信度为100%;图c SWE速度模式显示Emean:22.02 kPa
图3 SWE各参数预测PTC中央区淋巴结转移的受试者工作特征曲线
表1 PTC有无中央区淋巴结转移的Emax、Emean、Emin的比较(kPa,±s
表2 SWE各参数预测中央区淋巴结转移的效能
图4 SWE、BRAFV600E及两者联合预测中央区淋巴结转移的受试者工作特征曲线
表3 比较SWE、BRAFV600F及两者联合预测中央区淋巴结转移的效能(%)
1
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
2
La VC, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview [J]. Int J Cancer, 2015, 136(9): 2187-2195.
3
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017 [J]. CA Cancer J Clin, 2015, 60(5): 277-300.
4
Londero SC, Krogdahl A, Bastholt L, et al. Papillary thyroid carcinoma in Denmark, 1996-2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort [J]. Thyroid, 2015, 25(1): 78-84.
5
Bhatia KS, Lam AC, Pang SW, et al. Feasibility Study of Texture Analysis Using Ultrasound Shear Wave Elastography to Predict Malignancy in Thyroid Nodules [J]. Ultrasound Med Biol, 2016, 42(7): 1671-1680.
6
刘保娴, 梁瑾瑜, 谢晓燕, 等. 剪切波弹性成像与实时组织弹性成像技术在甲状腺结节良恶性鉴别诊断中的应用价值 [J/CD]. 中华医学超声杂志(电子版), 2014, 11(11): 57-62.
7
纪欢, 张蕾, 李守强, 等. 剪切波弹性成像联合超微血管显像在甲状腺肿块良恶性鉴别诊断中的应用 [J]. 中华超声影像学杂志, 2018, 27(2): 143-146.
8
Chakraborty A, Narkar A, Kane S, et al. V600E Mutation in Papillary Thyroid Carcinoma: Significant Association with Node Metastases and Extra Thyroidal Invasion [J]. Endocr Pathol, 2012, 23(2): 83-93.
9
Xing M, Alzahrani AS, Carson KA, et al. Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer [J]. J Clin Oncol, 2015, 33(1): 42-50.
10
Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? [J]. Cancer, 2017, 123(3): 372-381.
11
中华医学会内分泌学分会. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中华核医学与分子影像杂志, 2013, 28(2): 779-797.
12
Yan H, Zhou X, Hui J, et al. A Study on Central Lymph Node Metastasis in 543 cN0 Papillary Thyroid Carcinoma Patients [J]. Int J Endocrinol, 2016, 2016: 1878194.
13
刘文, 程若川, 苏艳军, 等. 甲状腺乳头状癌中央区淋巴结转移危险因素研究(附3273例回顾性分析) [J]. 中国实用外科杂志, 2018, 38(3): 316-321.
14
Na DK, Choi YJ, Choi SH, et al. Evaluation of cervical lymph node metastasis in thyroid cancer patients using real-time CT-navigated ultrasonography: preliminary study [J]. 2015, 34(1): 39-44
15
Ma B, Wang Y, Yang S, et al. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis [J]. Int J Surg, 2016, 28: 153-161.
16
Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression [J]. J Cell Biol, 2012, 196(4): 395.
17
Park AY, Kim JA, Son EJ, et al. Shear-Wave Elastography for Papillary Thyroid Carcinoma can Improve Prediction of Cervical Lymph Node Metastasis [J]. Ann Surg Oncol, 2016, 23(5): 722-729
18
Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia [J]. Nat Rev Cancer, 2006, 6(4): 292-306.
19
Kim TH, Park YJ, Lim JA, et al. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis [J]. Cancer, 2012, 118(7): 1764-1773.
20
石臣磊, 丁超, 秦华东, 等. BRAF(V600E)突变与乳头状甲状腺癌中央区淋巴结转移的关系 [J]. 中国普通外科杂志, 2014, 23(11): 1522-1526.
21
Han PA, Kim HS, Cho S, et al. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers [J]. Thyroid, 2016, 26(4): 532-542.
22
Kim MH, Bae JS, Lim DJ, et al. Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression [J]. Endocr Relat Cancer, 2014, 21(6): 891.
[1] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[2] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[3] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[4] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[5] 黄一博, 李至彦, 林晨, 陶亮, 王萌, 管文贤. 胃癌根治术中淋巴结示踪剂的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 586-588.
[6] 田文. 甲状腺癌功能性根治颈淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 482-482.
[7] 王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.
[8] 孙辉, 李长霖. 分化型甲状腺癌根治性切除术中的关键考量与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 477-481.
[9] 高一飞, 刘根祥, 孙长华, 周广军. 喉返神经监测在无充气腋窝入路腔镜单侧甲状腺切除+中央区淋巴结清扫术中的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 483-486.
[10] 李云龙, 夏旭良, 江志强, 刘伟, 刘凯, 唐立, 刘昊中, 张思远. 三种方法治疗分化型甲状腺癌的临床疗效[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 487-489.
[11] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[12] 何羽. 腔镜微创手术治疗分化型甲状腺癌的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 456-458.
[13] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[14] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要